Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis

Journal of Clinical Microbiology

Volumn 45, Issue 1, 2007, Pages 26-30

  Saubolle, Michael A ^a,b,c   McKellar, Peter P ^b,c   Sussland, Den ^a  

^a SONORA QUEST LABORATORIES   (United States)

^b BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

CLINICAL FEATURE; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; COUGHING; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEVER; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; MALAISE; MICROSCOPY; PRIORITY JOURNAL; SHORT SURVEY; THORAX PAIN;

ADULT; AGED; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; HUMANS; MIDDLE AGED;

EID: 33846237249     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02230-06     Document Type: Short Survey

References (14)

1. Ampel, N. 2000. Coccidioidomycosis, p. 59-77. In G. A. Sarosi and S. F. Davies (ed.), Fungal diseases of the lung. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Bialek, R., J. Kern, T. Herrman, R. Tijerina, L. Ceceñas, U. Reischl, and G. M. González. 2004. PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen. J. Clin. Microbiol. 42:778-783.
3. Chaturvedi, V., R. Ramani, S. Gromadzki, B. Rodeghier, H. Chang, and D. L. Morse. 2000. Coccidioidomycosis in New York State. Emerg. Infect. Dis. 6:25-29.
4. Fisher, M. C., G. L. Koenig, T. J. White, and J. W. Taylor. 2002. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 94:73-84.
5. Galgiani, J. N., N. M. Ampel, J. E. Blair, A. Catanzaro, R. H. Johnson, D. A. Stevens, and P. L. Williams. 2005. Coccidioidomycosis. Clin. Infect. Dis. 41:1217-1223.
6. Kirkland, T. N., and J. Fierer. 1996. Coccidioidomycosis: a reemerging infectious disease. Emerg. Infect. Dis. 3:192-199.
7. Miller, J. M. 2006. The select agent rule and its impact on clinical laboratories. Clin. Microbiol. Newsl. 28:57-63.
8. Odds, F. C., F. V. Van Gerven, A. Espinel-Ingroff, M. S. Bartlett, M. A. Ghannoum, M. V. Lancaster, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, and T. J. Walsh. 1998. Evaluation of possible correlations between antifungal susceptibilities and treatment outcomes in animal infection models. Antimicrob. Agents Chemother. 42:282-288.
9. Pappagianis, D. 1996. Serology of coccidioidomycosis, p. 33-35. In H. E. Enstein and A. Catanzaro (ed.), Coccidioidomycosis: proceedings of the 5th international conference. National Foundation for Infectious Diseases, Washington, DC.
10. Pappagianis, D., and B. L. Zimmer. 1990. Serology of coccidioidomycosis. Clin. Microbiol. Rev. 3:247-268.
11. Saubolle, M. A. 2000. Mycology and the clinical laboratory in the diagnosis of respiratory mycoses, p. 1-16. In G. A. Sarosi and S. F. Davies (ed.), Fungal diseases of the lung. Lippincott Williams & Wilkins, Philadelphia, PA.
12. Valdivia, L., D. Nix, M. Wright, E. Lindberg, T. Fagan, D. Lieberman, T. Stoffer, N. M. Ampel, and J. N. Galgiani. 2006. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg. Infect. Dis. 12: 958-962. (First published June 2006; http://www.cdc.gov/ncidod/EID /vol12no06/06-0028. htm.)
13. Wieden, M. A., and M. A. Saubolle. 1996. The histopathology of coccidioidomycosis, p. 12-17. In H. E. Einstein and A. Catanzaro (ed.), Coccidioidomycosis: proceedings of the 5th international conference. National Foundation for Infectious Diseases, Washington, DC.
14. Yeo, S. F., and B. Wong. 2002. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev. 15:465-484.